PepHookup

A search and discovery platform that connects patients with licensed providers offering peptide therapy. Includes a provider directory, long-form peptide education pages, and a live FDA tracker that follows the Category 2 reclassification timeline.

Visit site →

The Challenge

In 2023, the FDA restricted 19 peptides from compounding pharmacies. HHS began reclassifying them back in 2026, and a large patient base was about to start searching for providers again. No purpose-built directory existed. The site had to serve two audiences (patients browsing for care and providers claiming listings) while tracking a regulation that was still shifting.

The Approach

Built on Next.js 16 and Supabase with a zip-based provider search, long-form MDX education pages for 17 peptides, and a live FDA tracker tied to regulatory events. Added a provider signup and claim flow, an admin moderation console, a Resend email outbox drained by Vercel Cron, and Upstash rate limiting on every public form. The brand uses cream and pink with olive accents, which helps it sit apart from the usual healthcare directory look.

The Results

Launched a production platform with provider search, 17 peptide education pages, a regulatory tracker, provider onboarding, and admin moderation. Free early access pulls in providers ahead of the reclassification wave. Waitlist capture and weekly provider insights are ready for monetization.